Axios

Roughly 94% of Americans surveyed by Hiya, an app that blocks spammers, say they don't pick up the phone for unidentified callers due to the onslaught of robocalls.

Zoom out: State health departments across the U.S. use calls to perform contact tracing, which aims to help slow the spread of the coronavirus by encouraging quarantines and other precautions.

Far-right-friendly social network Parler is coming back online after going dark for more than a month, following suspensions from Google, Apple and Amazon in light of the Jan. 6 Capital siege.

Why it matters: Parler's de-platforming ignited a free speech debate over whether Big Tech giants have too much control over discourse in America and around the world.

Many people who have filed workers' compensation claims following COVID-19 infections are being denied, a Wall Street Journal analysis of state data shows.

Why it matters: Rejected claims from office employees, front-line workers, and airline staff suggest that it's hard to prove where an infection occurred and that returning to the workplace prior to widespread vaccination could present more danger — and less of a safety net — than previously thought.

In an interview with "Axios on HBO," New York Stock Exchange president Stacey Cunningham rejected comparisons between stock market investing and gambling.

Between the lines: Sen. Elizabeth Warren recently said "investors big and small are treating the stock market like a casino," in response to last month's situation with GameStop, Reddit and Robinhood. Cunningham says Warren is wrong.

The FBI offers some advice for the lovelorn on this Valentine's Day: The way to heartbreak is through your bank account.

Why it matters: The coronavirus pandemic has mostly left the search for love online, and the FBI says it's seen a rise in reports of scams that seem to offer romance, but are actually seeking to wrangle money or financial information from their victims.

Open-source the vaccines. That's the message being sent by the People's Vaccine Alliance, a coalition that includes Amnesty International, Oxfam, and UNAIDS.

Why it matters: Manufacturing capacity needs to be scaled up dramatically — and cutting out the need for laborious, expensive and secretive negotiations with vaccine patent holders could help.